1998
DOI: 10.3109/10401239809148817
|View full text |Cite
|
Sign up to set email alerts
|

Olanzapine-Induced Weight Gain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
7
0
2

Year Published

2001
2001
2009
2009

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 0 publications
3
7
0
2
Order By: Relevance
“…This finding is consistent with the data presented by other authors reporting on randomized controlled trials whose figures on weight gain were higher [11.15 kg over 7 months (Gupta et al, 1998); 11.8 kg over 1 year (Nemeroff, 1997)] as well as lower [8.0 kg over 73 weeks (Wirshing et al, 1999); 6.26 kg over 2.54 years ] than ours. Thus, we conclude that weight gain during olanzapine treatment under naturalistic conditions is approximately the same as in randomized controlled trials.…”
Section: Discussionsupporting
confidence: 95%
See 1 more Smart Citation
“…This finding is consistent with the data presented by other authors reporting on randomized controlled trials whose figures on weight gain were higher [11.15 kg over 7 months (Gupta et al, 1998); 11.8 kg over 1 year (Nemeroff, 1997)] as well as lower [8.0 kg over 73 weeks (Wirshing et al, 1999); 6.26 kg over 2.54 years ] than ours. Thus, we conclude that weight gain during olanzapine treatment under naturalistic conditions is approximately the same as in randomized controlled trials.…”
Section: Discussionsupporting
confidence: 95%
“…Only some authors present data for periods of more than half a year of olanzapine treatment (Nemeroff, 1997;Gupta et al, 1998;Wirshing et al, 1999;Jones et al, 2001;Kinon et al, 2001). Most of these studies used clinical trial data (Nemeroff, 1997;Wirshing et al, 1999;Jones et al, 2001;Kinon et al, 2001).…”
Section: Introductionmentioning
confidence: 94%
“…Obesity is a risk factor for type 2 diabetes, and weight gain is a well-known side effect of olanzapine. 15,16 Our patient' s weight gradually increased while he was taking olanzapine, and this phenomenon has been documented in other case reports. 4,9,17 The gradual, steady increase in weight just before his acute glycemic decompensation occurred may have played a role in its development.…”
Section: Discussionsupporting
confidence: 75%
“…Eine signifikante Gewichtszunahme tritt vor allem unter der Behandlung mit Clozapin und Olanzapin auf, die hauptsäch-lich durch eine Zunahme der Fettmasse mit gleichzeitigem Anstieg der Leptinspiegel bedingt ist [3,4,5,6]. Die antipsychotische Therapie mit Risperidon, Quetiapin und Amisulprid ist im Allgemeinen mit einer niedrigen bis moderaten Gewichtszunahme verbunden [7,8,9].…”
Section: > Diabetes Mellitus Typ 2 Und Metabolisches Syndrom Treten Bunclassified